amiloride (Q419995)

AMILORIDE (English)

17 November 2016

C₆H₈ClN₇O

1 reference

AMILORIDE (English)

17 November 2016

C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N

1 reference

AMILORIDE (English)

17 November 2016

C1(=C(N=C(C(=N1)Cl)N)N)/C(=N/C(=N)N)/O

1 reference

Amiloride (English)

17 November 2016

10 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C03DB01

World Health Organisation international non-proprietary name

amiloride (English)

1 reference

medical condition treated

Recommended INN: List 8

1 reference

13 December 2016

1 reference

13 December 2016

arterial hypertension

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

Food and Drug Administration

13 December 2016

arterial hypertension

start time

4 October 1981

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/7DZO8EB0Z3

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/18-200S024_Midamor_Prntlbl.pdf

congestive heart failure

start time

4 October 1981

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/7DZO8EB0Z3

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/18-200S024_Midamor_Prntlbl.pdf

significant drug interaction

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

acute kidney injury

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

increased blood creatinine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Acid sensing ion channel subunit 1

1 reference

Acid sensing ion channel subunit 2

17 August 2016

1 reference

Acid sensing ion channel subunit 3

17 August 2016

1 reference

Solute carrier family 9 member A5

17 August 2016

1 reference

Transient receptor potential cation channel, subfamily A, member 1

17 August 2016

1 reference

Transient receptor potential cation channel, subfamily C, member 6

17 August 2016

1 reference

Transient receptor potential cation channel subfamily C member 7

17 August 2016

1 reference

Polycystin 2 like 1, transient receptor potential cation channel

17 August 2016

1 reference

Transient receptor potential cation channel subfamily V member 2

17 August 2016

1 reference

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category B

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Amiloride

5 October 2017

1 reference

Medical Subject Headings

MeSH descriptor ID

D000584

Acid Sensing Ion Channel Blockers

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D000584

Epithelial Sodium Channel Blockers

15 March 2018

1 reference

Institute for Safe Medication Practices

Medical Subject Headings

15 March 2018

0 references

aMILoride

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

National Library of Latvia ID

2 September 2022

Commons category

Amiloride

0 references

Identifiers

000311872

0 references

InChI

InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)

1 reference

AMILORIDE (English)

17 November 2016

2 references

AMILORIDE (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2609-46-3

2 references

amiloride (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=2609-46-3

9 April 2021

1 reference

Amiloride (English)

17 November 2016

2 references

AMILORIDE (English)

17 November 2016

Reaxys registry number

616612

1 reference

amiloride (English)

19 October 2016

657410

1 reference

amiloride (English)

19 October 2016

mapping relation type

2 references

AMILORIDE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)

1 reference

AMILORIDE (English)

17 November 2016

2 references

inferred from InChIKey

SCHEMBL27563

2 references

based on heuristic

inferred from InChIKey

splash10-0089-1790000000-9f966f1f1f39d074086a

1 reference

MassBank accession ID

MSBNK-Keio_Univ-KO008833

0 references

MSBNK-Keio_Univ-KO008834

0 references

MSBNK-Keio_Univ-KO008835

0 references

MSBNK-Keio_Univ-KO002393

0 references

MSBNK-Keio_Univ-KO002394

0 references

MSBNK-Keio_Univ-KO002395

0 references

MSBNK-Keio_Univ-KO002396

0 references

MSBNK-Keio_Univ-KO002397

0 references

MSBNK-Waters-WA001192

0 references

MSBNK-Waters-WA001193

0 references

MSBNK-Waters-WA001194

0 references

MSBNK-Waters-WA001195

0 references

MSBNK-Waters-WA001196

0 references

SPLASH

0 references

splash10-00di-3900000000-9e3a3741c916f113d456

0 references

splash10-02tc-5900000000-f32cb47ea7e98516befc

0 references

splash10-02t9-8900000000-7f66a60319e15df262c2

0 references

splash10-00dr-1910000000-f028ae70e2d968afae25

0 references

splash10-00di-0900000000-a76fa198e6f147ebf51f

0 references

splash10-000i-0900000000-8f3aaddd905d255eeb9d

0 references

DSSTox substance ID

DTXSID9043853

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

220-024-7

1 reference

amiloride (English)

ECHA Substance Infocard ID

17 November 2016

100.018.205

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Amiloride (English)

CAS no.: 2609-46-3 (English)

AICS Chemical ID (BEING DELETED)

0 references

1 reference

World Health Organisation international non-proprietary name numeric ID

Amiloride (English)

publication date

17 November 2015

2352

0 references

1 reference

amiloride (English)

17 November 2016

Amiloride

0 references

0 references

0 references

1 reference

amiloride (English)

17 November 2016

1 reference

Human Metabolome Database ID

HMDB0014732

2 references

based on heuristic

inferred from InChIKey

2 references

amiloride (English)

17 November 2016

MedlinePlus drug identifier

a615029

0 references

PatientsLikeMe treatment ID

0 references

1 reference

amiloride (English)

17 November 2016

0 references

0 references

1 reference

amiloride (English)

19 October 2016

1 reference

electronic Essential Medicines List medicine ID

amiloride (English)

19 October 2016

0 references

0 references

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

4NTX (English)

19 October 2016

1 reference

1F5L (English)

19 October 2016

1 reference